Results 231 to 240 of about 47,532 (242)

A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder.

Psychopharmacology bulletin
OBJECTIVE To compare the efficacy and safety of bupropion XL (150 to 300 mg/day) with the selective serotonin reuptake inhibitor escitalopram (10 to 20 mg/day) in outpatients diagnosed with generalized anxiety disorder (GAD).
A. Bystritsky, Lauren E Kerwin, Jamie D. Feusner, T. Vapnik   +3 more
semanticscholar   +1 more source

Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects

Drug metabolism reviews (Softcover ed.), 2019
Bupropion is an atypical antidepressant of the aminoketone group, structurally related to cathinone, associated with a wide interindividual variability. An extensive pharmacokinetic and pharmacodynamic review of bupropion was performed, also focusing on ...
R. Costa, N. Oliveira, R. Dinis-Oliveira
semanticscholar   +1 more source

Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.

Psychopharmacology bulletin
Principal component (PC) analysis is a statistical technique that has been used to identify core depression symptoms on the Hamilton Rating Scale for Depression (HAM-D).
B. Jamerson, K. Krishnan, J. Roberts, A. Krishen, J. G. Modell   +4 more
semanticscholar   +1 more source

Bupropion sustained release for panic disorder.

Psychopharmacology bulletin
Despite anecdotal reports suggesting that bupropion may be effective for panic disorder, both clinical lore and the results of one small controlled study suggest otherwise.
N. Simon, N. Emmanuel, J. Ballenger, J. Worthington, G. Kinrys, N. Korbly, Frank J. Farach, M. Pollack   +7 more
semanticscholar   +1 more source

Dextromethorphan/Bupropion: First Approval

CNS Drugs, 2022
S. Keam
semanticscholar   +1 more source

Potential Role of Bupropion Sustained Release for Cancer-Related Fatigue: a Double-Blind, Placebo-Controlled Study

Asian Pacific Journal of Cancer Prevention, 2018
Background: Cancer-related fatigue (CRF) is very common and can be experienced at all stages of disease and in survivors. CRF causes patients more distress than pain or nausea and vomiting.
Farzaneh Ashrafi, Sarah Mousavi, M. Karimi   +2 more
semanticscholar   +1 more source

Bupropion Ameliorates Acetic Acid–Induced Colitis in Rat: the Involvement of the TLR4/NF-kB Signaling Pathway

Inflammation, 2020
Amir Rashidian, Pegah Dejban, Kiana Karami Fard, A. Abdollahi, M. Chamanara, A. Dehpour, A. Hasanvand   +6 more
semanticscholar   +1 more source

Bupropion increases activation in nucleus accumbens during anticipation of monetary reward

Psychopharmacology, 2019
Y. Ikeda, Takuya Funayama, Amane Tateno, H. Fukayama, Y. Okubo, Hidenori Suzuki   +5 more
semanticscholar   +1 more source

Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial

, 2006
D. Jorenby, J. Hays, N. Rigotti, S. Azoulay, E. Watsky, K. Williams, C. Billing, Jason Gong, K. Reeves   +8 more
semanticscholar   +1 more source

Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial

, 2006
D. Gonzales, S. Rennard, M. Nides, C. Oncken, S. Azoulay, C. Billing, Watsky Eric Jacob, Jason Gong, K. Williams, K. Reeves   +9 more
semanticscholar   +1 more source